James Rippe, M.D., Renowned Cardiologist and Health Expert at New York Academy of Sciences, to Introduce Groundbreaking Laser Technology to Measure Overall Antioxidant Health

Press Release

Monday February 3, 9:31 am ET

Event: Join Dr. James Rippe and other scientific experts for a panel discussion of clinical data on the role of antioxidants in fighting free radicals and a demonstration of the Pharmanex® BioPhotonic Scanner -- the first immediate and noninvasive instrument able to measure antioxidant status in living tissue.

Background: Dr. James Rippe, renowned cardiologist and internationally recognized researcher, is considered the leader and pioneer in modern linkages between health and lifestyle. A graduate of Harvard College and Harvard Medical School, with post-graduate training at Massachusetts General Hospital, Dr. Rippe is widely acknowledged as a leader in both lifestyle and subspecialty medicine. Dr. Rippe has been featured nationwide as a medical expert on major networks, including the "Today Show" and "Good Morning America." He is also a regular guest on the "CBS Early Show." His most recent interview in Business Week's December 30, 2002 Special Double Issue focused on annual medical evaluations for top executives. He is regularly featured on the "Golf Channel" and serves as an Associate Clinical Professor of Medicine at Tufts University. For more information about Dr. Rippe and the Rippe Lifestyle Institute, visit www.rippehealth.com/About.htm.

Availability: Dr. Rippe will be available for a panel discussion on antioxidant and lifestyle research as well as the latest technology available to measure overall antioxidant health. For more information on the Pharmanex BioPhotonic Scanner, visit www.pharmanexscanner.com.

When: 10:00 a.m. Wednesday, February 5, 2003

Where: New York Academy of Sciences, 2 East 63rd St., NY, NY 10021

Contact: To attend the symposium, or to arrange a private one-on-one interview with Dr. Rippe, contact Amy Dimond at 801-345-2113 or Deena Barghothi at 201-217-0111.


Source: Pharmanex

[Read Original Article]

Back to "AO Scanner" Page
Back to Headlines